Early biomarkers for Alzheimer’s disease

Blood biomarkers are taking off in the Alzheimer’s disease field, showing promise for diagnosis, prognostication, and treatment monitoring. Research groups across the globe are assessing biomarkers in the very earliest stages of disease.

In this episode, Marta Milà-Alomà, PhD; Pamela Lukasewicz Ferreira, PhD; Madison Honey, PhD candidate; and Zahinoor Ismail, MD, share their latest work looking at early biomarkers, from plasma biomarkers to mild behavioral impairment.